Five facility certificates published
Certification Assurance International issued Lyotek Labs five facility certificates on 27 October 2026, and all of them are now published on this site as the issuer's PDFs.
All press releases
Growth hormone axis range opens with Tesamorelin, CJC-1295 and Ipamorelin
Three research peptides open a new section of the Lyotek catalogue: Tesamorelin at 20 mg, and CJC-1295 and Ipamorelin at 10 mg each.
These are the first growth hormone axis peptides Lyotek has made, and the range was built around the compounds research groups asked us for most often.
All three are lyophilised in 3 ml vials with flip-off closures, and each lot is released with a certificate of analysis that can be looked up from the code on its label.
The growth hormone axis range is for research use only.
Lyotek products are supplied for research use only.
More from the laboratory
Lyotek research peptides now reach more than 170 countries
Through its exclusive distributor, Lyotek research peptides now reach laboratories in more than 170 countries from the laboratory in Switzerland.
Our exclusive distributor expands to the Middle East, Southeast Asia and Latin America
Lyotek's exclusive distributor has extended its coverage to three new regions, which brings local support to laboratories there.